Risperidone attenuates acetic acid-induced colitis in rats through inhibition of TLR4/NF-kB signaling pathway

References

• Tasdemir S, Parlakpinar H, Vardi N, et al. Effect of endogen-exogenous melatonin and erythropoietin on dinitrobenzene sulfonic acid-induced colitis. Fundam Clin Pharmacol. 2013;27(3):299–307.
   PubMed Web of Science ®Google Scholar
• Molodecky NA, Soon S, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54.e42.
   PubMed Web of Science ®Google Scholar
• Chung SH, Park YS, Kim OS, et al. Melatonin attenuates dextran sodium sulfate induced colitis with sleep deprivation: possible mechanism by microarray analysis. Dig Dis Sci. 2014;59(6):1134–1141.
   PubMed Web of Science ®Google Scholar
• Rashidian A, Roohi P, Mehrzadi S, et al. Protective effect of ocimum basilicum essential oil against acetic acid-induced colitis in rats. J Evid Based Complementary Altern Med. 2016;21(4):NP36–NP42.
   PubMedGoogle Scholar
• Zeng Z, Zhan L, Liao H, et al. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway. Planta Med. 2012;79(02):102–109.
   PubMedGoogle Scholar
• Rashidian A, Rashki A, Abdollahi A, et al. Dapsone reduced acetic acid-induced inflammatory response in rat colon tissue through inhibition of NF-kB signaling pathway. Immunopharmacol Immunotoxicol. 2019;41(6):607–613.
   PubMed Web of Science ®Google Scholar
• Rogler G. Gastrointestinal and liver adverse effects of drugs used for treating IBD. Best Pract Res Clin Gastroenterol. 2010;24(2):157–165.
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol. 2001;1(2):135–145.
   PubMed Web of Science ®Google Scholar
• Xia MZ, Liang YL, Wang H, et al. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells. J Pineal Res. 2012;53(4):325–334.
   PubMed Web of Science ®Google Scholar
• Kang JW, Koh EJ, Lee SM. Melatonin protects liver against ischemia and reperfusion injury through inhibition of toll-like receptor signaling pathway. J Pineal Res. 2011;50(4):403–411.
   PubMed Web of Science ®Google Scholar
• Vriend J, Reiter RJ. Melatonin as a proteasome inhibitor. Is there any clinical evidence? Life Sci. 2014;115(1–2):8–14.
   PubMed Web of Science ®Google Scholar
• Lin GJ, Huang SH, Chen SJ, et al. Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases. Int J Mol Sci. 2013;14(6):11742–11766.
   PubMed Web of Science ®Google Scholar
• Luo JL, Kamata H, Karin M. IKK/NF-kappaB signaling: balancing life and death-a new approach to cancer therapy. J Clin Invest. 2005;115(10):2625–2632.
   PubMed Web of Science ®Google Scholar
• Rezayat SM, Dehpour AR, Motamed SM, et al. Foeniculum vulgare essential oil ameliorates acetic acid-induced colitis in rats through the inhibition of NF-kB pathway. Inflammopharmacol. 2018;26(3):851–859.
   PubMed Web of Science ®Google Scholar
• Rashidian A, Muhammadnejad A, Dehpour AR, et al. Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway. Inflammopharmacology. 2016;24(2–3):109–118.
   PubMed Web of Science ®Google Scholar
• Kapur S, Remington G. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annu Rev Med. 2001;52(1):503–517.
   PubMedGoogle Scholar
• Abou El-Magd R, Park H, Kawazoe T, et al. The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia. J Psychopharmacol. 2010;24(7):1055–1067.
   PubMed Web of Science ®Google Scholar
• MacDowell KS, García-Bueno B, Madrigal JL, et al. Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation. Int J Neuropsychopharmacol. 2013;16(1):121–135.
   PubMed Web of Science ®Google Scholar
• Al-Amin M, Choudhury M, Rahman F, et al. Pretreatment with risperidone ameliorates systemic LPS-induced oxidative stress in the cortex and hippocampus. Front Neurosci. 2018;12:384.
   PubMed Web of Science ®Google Scholar
• Al-Amin MM, Uddin MMN, Reza HM. Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures. Clin Psychopharmacol Neurosci. 2013;11(3):144–151.
   PubMed Web of Science ®Google Scholar
• O’Sullivan D, Green L, Stone S, et al. Treatment with the antipsychotic agent, risperidone, reduces disease severity in experimental autoimmune encephalomyelitis. PLoS One. 2014;9(8):e104430.
   PubMed Web of Science ®Google Scholar
• Deshmukh C, Veeresh B, Pawar A. Protective effect of Emblica officinalis fruit extract on acetic acid induced colitis in rats. J Herbal Med Toxicol. 2010;4(2):83–87.
   Google Scholar
• Khan I, Oriowo MA, Anim JT. Amelioration of experimental colitis by Na-H exchanger-1 inhibitor amiloride is associated with reversal of IL-1ss and ERK mitogen-activated protein kinase. Scand J Gastroenterol. 2005;40(5):578–585.
   PubMed Web of Science ®Google Scholar
• Bradley PP, Priebat DA, Christensen RD, et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78(3):206–209.
   PubMed Web of Science ®Google Scholar
• Allred D, Harvey JM, Berardo M, et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod pathol. 1998;11(2):155–168.
   PubMed Web of Science ®Google Scholar
• Lane ER, Zisman TL, Suskind DL. The microbiota in inflammatory bowel disease: current and therapeutic insights. J Inflamm Res. 2017;10:63–73.
   PubMed Web of Science ®Google Scholar
• Goyal N, Rana A, Ahlawat A, et al. Animal models of inflammatory bowel disease: a review. Inflammopharmacology. 2014;22(4):219–233.
   PubMed Web of Science ®Google Scholar
• Sugino H, Futamura T, Mitsumoto Y, et al. Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(2):303–307.
   PubMed Web of Science ®Google Scholar
• Noto C, Ota VK, Gouvea ES, et al. Effects of risperidone on cytokine profile in drug-naive first-episode psychosis. Int J Neuropsychopharmacol. 2015;18(4):pyu042–pyu042.
   Web of Science ®Google Scholar
• Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol. 2005;77(5):598–625.
   PubMed Web of Science ®Google Scholar
• Kojouharoff G, Hans W, Obermeier F, et al. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol. 1997;107(2):353–358.
   PubMed Web of Science ®Google Scholar
• Ungaro R, Fukata M, Hsu D, et al. A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol. 2009;296(6):G1167–79.
   PubMed Web of Science ®Google Scholar
• Szebeni B, Veres G, Dezsofi A, et al. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease. Clin Exp Immunol. 2008;151(1):34–41.
   PubMed Web of Science ®Google Scholar
• Fort MM, Mozaffarian A, Stover AG, et al. A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J Immunol. 2005;174(10):6416–6423.
   PubMed Web of Science ®Google Scholar
• Andresen L, Jorgensen VL, Perner A, et al. Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut. 2005;54(4):503–509.
   PubMed Web of Science ®Google Scholar
• Dou W, Zhang J, Sun A, et al. Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-κB signalling. Br J Nutr. 2013;110(4):599–608.
   PubMed Web of Science ®Google Scholar
• Cheng J, Shah YM, Ma X, et al. Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation. J Pharmacol Exp Ther. 2010;335(1):32–41.
   PubMed Web of Science ®Google Scholar